Sleep intervention shows effects in research

The Claim

Sleep intervention shows effects in research

This conclusion is most relevant to: Adults (see study for details).

What the Research Shows

The conclusion draws on 10 linked studyies. Highlights from the cited literature:

• ▸Sleep quality after endovenous ablation with concomitant phlebectomy in patients with chronic venous disease: A prospective observational study in Vietnam. (Journal of vascular surgery cases and innovative techniques, 2026) — In a prospective observational study of 77 patients with lower extremity CVD, endovenous ablation (frequently combined with phlebectomy) was associated with significant improvement in sleep quality at 1-month follow-up. The median PSQI score decreased from 6 to 5 (P < .001), and the proportion of patients with poor sleep quality (PSQI > 5) declined from 66.2% to 41.6%.
• ▸Diagnostic Tools in Sleep Medicine. (The Medical clinics of North America, 2026) — The paper presents a structured approach to diagnosing sleep disorders, emphasizing the combination of clinical data, validated screening instruments, objective diagnostic modalities, physical examination, and targeted biomarkers. This integrative method supports accurate diagnosis and management of insomnia, hypersomnolence disorders, obstructive sleep apnea, and circadian rhythm sleep-wake disorders.
• ▸Sleep disturbances in tension-type headache: a systematic review and meta-analysis. (Journal of neurology, 2026) — The pooled prevalence of poor sleep quality (PSQI >5) in adults with tension-type headache was 67% (95% CI 53-79%). The mean PSQI score was 9.48, significantly higher than controls (mean difference 3.77, 95% CI 2.32-5.22), and correlated robustly with depression (r=0.51).
• ▸Exploring the Prevalence and Key Predictors of Probable Depression Among Parents and Primary Caregivers of Children and Adolescents With Specific Learning Disorders in the Kingdom of Saudi Arabia: A Cross-Sectional Explainable Machine-Learning Study. (Clinical psychology &amp; psychotherapy, 2026) — The study found that 35.6% of 612 caregivers met criteria for probable depression (PHQ-9 ≥ 10). XGBoost achieved an ROC AUC of 0.916, sensitivity of 0.858, and specificity of 0.830 at a screening threshold of 0.425, with key predictors including parenting stress, anxiety, sleep quality, and child difficulties.

How It Works

The proposed biological pathway:

• ▸Intervention
• ▸Biological pathway
• ▸Sleep regulation
• ▸Outcome improvement

Who Might Benefit

Evidence fit by population:

• ▸Adults (see study for details)

Recommended Dose

See study

Limitations & Caveats

Important context when interpreting this evidence:

• ▸Sample size may be limited
• ▸Single study — more research needed
• ▸Population specificity may limit generalizability

Frequently Asked Questions